1_49_0

SRS15854293 SAMN31854119 GSM6754319 1_49_0_S12 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854294 SAMN31854118 GSM6754320 1_49_2_S13 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine (dose reduced) time 24h SRS15854295 SAMN31854117 GSM6754321 1_5_0_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Pre-treatment time 0h SRS15854296 SAMN31854116 GSM6754322 1_5_1_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Daunorubicine + Cytarabine time 4h SRS15854297 SAMN31854115 GSM6754323 1_5_2_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Daunorubicine + Cytarabine time 24h SRS15854298 SAMN31854114 GSM6754324 1_53_0_S3 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854299 SAMN31854113 GSM6754325 1_53_1_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 4h SRS15854300 SAMN31854112 GSM6754326 1_53_2_S11 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 24h SRS15854301 SAMN31854111 GSM6754327 1_55_0_S5 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854302 SAMN31854110 GSM6754328 1_55_1_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 4h SRS15854303 SAMN31854109 GSM6754329 1_55_2_S13 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 24h SRS15854304 SAMN31854108 GSM6754330 1_62_0_S16 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Pre-treatment time 0h SRS15854305 SAMN31854107 GSM6754331 1_62_1_S19 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Daunorubicine + Cytarabine time 4h SRS15854306 SAMN31854106 GSM6754332 1_62_2_S22 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Daunorubicine + Cytarabine time 24h SRS15854307 SAMN31854105 GSM6754333 1_66_0_S14 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype t(11;21)(q23;q11.2) RUNX1 treatment Pre-treatment time 0h SRS15854308 SAMN31854104 GSM6754334 1_66_2_S15 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype t(11;21)(q23;q11.2) RUNX1 treatment Daunorubicine + Cytarabine (dose reduced) time 24h SRS15854309 SAMN31854103 GSM6754335 1_67_0_S8 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854310 SAMN31854102 GSM6754336 1_67_2_S12 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 24h SRS15854311 SAMN31854101 GSM6754337 1_68_0_S10 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854312 SAMN31854100 GSM6754338 1_68_2_S11 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 24h SRS15854313 SAMN31854099 GSM6754339 1_71_0_S25 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype inv (3) MECOM treatment Pre-treatment time 0h SRS15854314 SAMN31854098 GSM6754340 1_71_1_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype inv (3) MECOM treatment Daunorubicine + Cytarabine time 4h SRS15854315 SAMN31854097 GSM6754341 1_71_2_S6 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype inv (3) MECOM treatment Daunorubicine + Cytarabine time 24h SRS15854316 SAMN31854096 GSM6754342 1_8_0_S24 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype -7/7q treatment Pre-treatment time 0h SRS15854317 SAMN31854095 GSM6754343 1_8_1_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype -7/7q treatment Daunorubicine + Cytarabine time 4h SRS15854318 SAMN31854094 GSM6754344 1_8_2_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype -7/7q treatment Daunorubicine + Cytarabine time 24h SRS15854319 SAMN31854093 GSM6754345 2_1_0_S1 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Inv (16) CBFB/MYH11 treatment Pre-treatment time 0h SRS15854320 SAMN31854092 GSM6754346 2_15_0_S17 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854321 SAMN31854091 GSM6754347 2_18_0_S18 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854322 SAMN31854090 GSM6754348 2_3_0_merged 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Pre-treatment time 0h SRS15854323 SAMN31854089 GSM6754349 2_3_1_S18 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 4h SRS15854324 SAMN31854088 GSM6754350 2_3_2_S21 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Normal treatment Daunorubicine + Cytarabine time 24h SRS15854325 SAMN31854087 GSM6754351 2_5_0_S16 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype Trisomy 10 treatment Pre-treatment time 0h SRS15854326 SAMN31854086 GSM6754352 2_9_0_S20 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype NA treatment Pre-treatment time 0h SRS15854327 SAMN31854085 GSM6754353 2_9_1_S23 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype NA treatment Daunorubicine + Cytarabine time 4h SRS15854328 SAMN31854084 GSM6754354 2_9_2_S26 9606 Homo sapiens bioproject 904775 PRJNA904775 source_name Whole blood disease state acute myeloid leukemia (AML) tissue Whole blood cell type PBMC genotype NA treatment Daunorubicine + Cytarabine time 24h